Neuralstem Announces the Closing of $20 Million Strategic Investment from Tianjin Pharmaceutical Group International Holdings Pharmaceutical Investing
Reata Pharmaceuticals Announces Requested Withdrawal of Registration Statement Due to Adverse Market Conditions Pharmaceutical Investing
Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND Pharmaceutical Investing
Cellular Biomedicine Group Announces Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoin™ Off-the-Shelf Allogeneic Stem Cell Therapy Genetics Investing
Valneva Receives FDA and European Approvals to Start Clinical Testing of Lyme Disease Vaccine Candidate Life Science Investing
Genomic Health Announces Results from Multiple Oncotype DX® Studies for Breast Cancer Genetics Investing
